newsfilter
← Latest News
Business Wire·

ImmunoCellular Therapeutics Provides Update on Corporate Milestones

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today provided an update on current and anticipated corporate milestones.